InSightech rotissa fibroid treament systems release-Health Imaging & IT

InSightech exempt new ExAblate 1 and the upcoming meeting of ExAblate or products Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

InSightech said ExAblate One and or products employ active ULTRASOUND non-invasive Interventional processing and testing rotissa poor, adenomyosis breast and prostate cancers, and other women's health information.

ExAblate-1 indicates heats and destroys body tissue and fluid displacement into the targeted bone käyttäminenUusi instructions of MR. ExAblate-1 provides real-time temperature data processed tissues and can be used to handle large and vascular poor, said Israel in Trat Carmel-based InSightech.
Last updated (Sunday, 03 October 2010)

View the original article here